BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 23551622)

  • 1. Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction.
    Buvat J; Büttner H; Hatzimouratidis K; Vendeira PA; Moncada I; Boehmer M; Henneges C; Boess FG
    J Sex Med; 2013 Jun; 10(6):1592-602. PubMed ID: 23551622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs. tadalafil or sildenafil on-demand in men with erectile dysfunction.
    Rubio-Aurioles E; Porst H; Kim ED; Montorsi F; Hackett G; Morales AM; Stuckey B; Būttner H; West TM; Huynh NN; Lenero E; Burns P; Kopernicky V
    J Sex Med; 2012 May; 9(5):1418-29. PubMed ID: 22429760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil.
    Kim E; Seftel A; Goldfischer E; Baygani S; Burns P
    Curr Med Res Opin; 2015 Feb; 31(2):379-89. PubMed ID: 25455432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial outcomes after initial treatment of erectile dysfunction with tadalafil once daily, tadalafil on demand or sildenafil citrate on demand: results from a randomized, open-label study.
    Hatzimouratidis K; Buvat J; Büttner H; Vendeira PA; Moncada I; Boehmer M; Henneges C; Boess FG
    Int J Impot Res; 2014; 26(6):223-9. PubMed ID: 24784894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy.
    Kim ED; Seftel AD; Goldfischer ER; Ni X; Burns PR
    J Sex Med; 2014 Mar; 11(3):820-30. PubMed ID: 23841532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial outcomes and drug attributes affecting treatment choice in men receiving sildenafil citrate and tadalafil for the treatment of erectile dysfunction: results of a multicenter, randomized, open-label, crossover study.
    Dean J; Hackett GI; Gentile V; Pirozzi-Farina F; Rosen RC; Zhao Y; Warner MR; Beardsworth A
    J Sex Med; 2006 Jul; 3(4):650-661. PubMed ID: 16839321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Continuous Dosing of Tadalafil Once Daily vs Tadalafil On Demand in Clinical Subgroups of Men With Erectile Dysfunction: A Descriptive Comparison Using the Integrated Tadalafil Databases.
    Brock G; Ni X; Oelke M; Mulhall J; Rosenberg M; Seftel A; D'Souza D; Barry J
    J Sex Med; 2016 May; 13(5):860-75. PubMed ID: 27114197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment satisfaction of men and partners following switch from on-demand phosphodiesterase type 5 inhibitor therapy to tadalafil 5 mg once daily.
    Burns PR; Rosen RC; Dunn M; Baygani SK; Perelman MA
    J Sex Med; 2015 Mar; 12(3):720-7. PubMed ID: 25615445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tadalafil once daily or on demand versus placebo on time to recovery of erectile function in patients after bilateral nerve-sparing radical prostatectomy.
    Moncada I; de Bethencourt FR; Lledó-García E; Romero-Otero J; Turbi C; Büttner H; Henneges C; Martinez Salamanca JI
    World J Urol; 2015 Jul; 33(7):1031-8. PubMed ID: 25155034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Tadalafil Once Daily on Penile Length Loss and Morning Erections in Patients After Bilateral Nerve-sparing Radical Prostatectomy: Results From a Randomized Controlled Trial.
    Brock G; Montorsi F; Costa P; Shah N; Martinez-Jabaloyas JM; Hammerer P; Ludovico GM; Lee JC; Henneges C; Hamidi K; Rossi A; Mulhall J; Büttner H
    Urology; 2015 May; 85(5):1090-1096. PubMed ID: 25813656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy.
    Eardley I; Mirone V; Montorsi F; Ralph D; Kell P; Warner MR; Zhao Y; Beardsworth A
    BJU Int; 2005 Dec; 96(9):1323-32. PubMed ID: 16287454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Tadalafil Once-Daily or On-Demand vs Placebo on Return to Baseline Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy--Results from a Randomized Controlled Trial (REACTT).
    Mulhall JP; Brock G; Oelke M; Fode M; Probst KA; Henneges C; d'Anzeo G; Rossi A; Büttner H
    J Sex Med; 2016 Apr; 13(4):679-83. PubMed ID: 27045264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective, randomized, open-label, fixed-dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE-5 inhibitors.
    Tolrà JR; Campaña JMC; Ciutat LF; Miranda EF
    J Sex Med; 2006 Sep; 3(5):901-909. PubMed ID: 16942534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuation and effectiveness of tadalafil once daily during a 6-month observational study in erectile dysfunction: the EDATE study.
    Buvat J; Hatzichristou D; Boess FG; Büttner H; Gehchan N; Henneges C; Porst H
    Int J Clin Pract; 2014 Sep; 68(9):1087-99. PubMed ID: 25123817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate.
    Broderick GA; Donatucci CF; Hatzichristou D; Torres LO; Valiquette L; Zhao Y; Loughney K; Sides GD; Ahuja S
    J Sex Med; 2006 Jul; 3(4):668-675. PubMed ID: 16839323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of tadalafil 20 mg on demand vs. tadalafil 5 mg once-a-day in the treatment of post-radiotherapy erectile dysfunction in prostate cancer men: a randomized phase II trial.
    Ricardi U; Gontero P; Ciammella P; Badellino S; Valentino F; Munoz F; Guarneri A; Rondi N; Moretto F; Filippi AR; Ragona R; Tizzani A
    J Sex Med; 2010 Aug; 7(8):2851-9. PubMed ID: 21711479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.
    Porst H; Gacci M; Büttner H; Henneges C; Boess F
    Eur Urol; 2014 Feb; 65(2):455-64. PubMed ID: 24119319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of dose relative to sexual intercourse attempt in previous sildenafil citrate users treated with tadalafil.
    Glina S; Sotomayor M; Gatchalian E; Yaman O; Dyachkova Y; Markey C; Kopernicky V
    J Sex Med; 2006 Mar; 3(2):309-19. PubMed ID: 16490025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.